Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y3RN
|
|||
Former ID |
DIB003809
|
|||
Drug Name |
BAY-Y-1015
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Discontinued in Phase 1 | [1] | |
Company |
Bayer AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H30N2O4S
|
|||
Canonical SMILES |
CS(=O)(=O)NC(=O)C(C1CCCCCC1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3
|
|||
InChI |
1S/C26H30N2O4S/c1-33(30,31)28-26(29)25(20-9-4-2-3-5-10-20)21-13-16-23(17-14-21)32-18-22-15-12-19-8-6-7-11-24(19)27-22/h6-8,11-17,20,25H,2-5,9-10,18H2,1H3,(H,28,29)/t25-/m1/s1
|
|||
InChIKey |
YAWBFCPZMALJCE-RUZDIDTESA-N
|
|||
CAS Number |
CAS 133012-05-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Leukotriene receptor (LTR) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005124) | |||
REF 2 | The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation. Arthritis Rheum. 1996 Mar;39(3):515-21. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.